5 research outputs found
Additional file 1: of Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
SPIRIT checklist. (DOC 122 kb
MOESM1 of Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
Additional file 1. Figures
Additional file 2: Table S1. of Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study
Separate multivariate cox-analysis. (PDF 290 kb
Additional file 3: Figure S2. of Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study
Calibration plots at 48Â months for the final multivariate model. Vertical axis is the observed proportion of patients surviving at time of interest. Grey line represents a perfectly calibrated model. Solid line is current prediction model performance with 95Â % confidence intervals using bootstrap resampling procedure. (PDF 146Â kb